DRDO released guidelines regarding Corona drug 2DG

DRDO released guidelines regarding Corona drug 2DG

New Delhi: The Defense Research and Development Organization (DRDO) has issued guidelines for the use of its 2DG (2-deoxy-D-glucose) drug in corona virus patients. It said that medicines can be given to Kovid patients under the supervision and prescription of doctors.

The 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences, the laboratory of DRDO.

Four guidelines for the use of 2DG:
2DG has been approved for emergency use as an adjuvant therapy of care in the treatment of Kovid patients in the hospital.

2DG should be prescribed as soon as possible by doctors for a period of up to 10 days for moderate to severe covid patients.

Patients with uncontrolled diabetes, severe heart problem, ARDS (acute respiratory distress syndrome), severe liver and renal impairment have not yet been studied with 2DG, so caution should be exercised.

2DG should not be given to pregnant and lactating women and patients under 18 years of age.

The DRDO also stated that patients and attendants are advised to request their hospital to contact Dr. Reddy’s Lab for the supply of medicines. On May 17, Defense Minister Rajnath Singh and Union Health Minister Dr. Harsh Vardhan released the first batch of medicine.

Reports say that the test results have shown that it helps in faster recovery of hospitalized patients and reduces oxygen dependence.

On May 28, Dr. Reddy’s announced that it had fixed the price of the drug at Rs 990 per pouch. However, the medicine will be made available to the central and state government hospitals at a discounted price.